These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 1960917
1. [Management of INH and RFP-resistant refractory tuberculosis]. Kekkaku; 1991 Oct; 66(10):687-706. PubMed ID: 1960917 [Abstract] [Full Text] [Related]
2. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis]. Saito W, Nagayama N, Miyamoto M, Hara H, Suzuki J, Masuda K, Baba M, Tamura A, Nagai H, Akagawa S, Kawabe Y, Machida K, Kurashima A, Yotsumoto H. Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568 [Abstract] [Full Text] [Related]
4. [Attributable factors to the emergence of multidrug-resistant Mycobacterium tuberculosis based on the observation of consecutive drug resistance test results]. Fujino T, Hasegawa N, Satou R, Komatsu H, Kawada K. Kekkaku; 1998 Jul; 73(7):471-6. PubMed ID: 9739579 [Abstract] [Full Text] [Related]
5. [Retreatment of pulmonary tuberculosis--duration of chemotherapy]. Wada M, Seita A, Mori T, Ogata H, Sugie T, Sugita H. Kekkaku; 1993 Jul; 68(7):469-78. PubMed ID: 8361115 [Abstract] [Full Text] [Related]
6. [Chemotherapy of pulmonary Mycobacterium kansasii infection]. Mizutani S. Kekkaku; 1996 Sep; 71(9):527-31. PubMed ID: 8914388 [Abstract] [Full Text] [Related]
7. [Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin]. Baba H. Kekkaku; 1994 Jun; 69(6):387-96. PubMed ID: 8041057 [Abstract] [Full Text] [Related]
8. [Treatment results of rifampicin (RFP) resistant isoniazid (INH) susceptible tuberculosis, a hospital based study]. Yoshiyama T, Ogata H, Ito K, Aono A, Wada M. Kekkaku; 2007 Feb; 82(2):95-101. PubMed ID: 17373318 [Abstract] [Full Text] [Related]
9. [Development of antituberculous drugs: current status and future prospects]. Tomioka H, Namba K. Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [Abstract] [Full Text] [Related]
10. [Two cases of long-lasting SPCN status]. Yokouchi H. Kekkaku; 1989 Jul; 64(7):475-7. PubMed ID: 2511374 [Abstract] [Full Text] [Related]
11. [Treatment outcomes of multidrug-resistant tuberculosis--comparison between success and failure cases]. Shigetoh E, Murakami I, Yokosaki Y, Kurimoto N. Kekkaku; 2001 Dec; 76(12):723-8. PubMed ID: 11806128 [Abstract] [Full Text] [Related]
12. [Exogenous re-infection in tuberculosis]. Tsuchiya T. Kekkaku; 2006 Feb; 81(2):79-91. PubMed ID: 16529009 [Abstract] [Full Text] [Related]
14. Multidrug-resistant tuberculosis at Srinagarind Hospital, Khon Kaen, Thailand. Reechaipichitkul W. Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):570-4. PubMed ID: 12693593 [Abstract] [Full Text] [Related]
15. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis. Becerra MC, Freeman J, Bayona J, Shin SS, Kim JY, Furin JJ, Werner B, Sloutsky A, Timperi R, Wilson ME, Pagano M, Farmer PE. Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087 [Abstract] [Full Text] [Related]
16. [A case of drug-resistant pulmonary tuberculosis treated successfully following disappearance of rifampicin resistance after 17 years' chemotherapy]. Shigeto E, Murakami I, Yokosaki Y. Kekkaku; 2001 Apr; 76(4):379-83. PubMed ID: 11398329 [Abstract] [Full Text] [Related]
17. [The role of surgery in pulmonary tuberculosis infected by tubercle bacilli with multiple drug resistance]. Anno H. Kekkaku; 1991 Nov; 66(11):763-7. PubMed ID: 1766157 [Abstract] [Full Text] [Related]